Accelerating growth through proactive business alliances and M&A
"Stable management" based on two businesses
The main "Pharmacy Business" and the "Medical-Related Business," which is independent of government policies
Currently, the Qol Group has realized stable management by optimizing its business portfolio with the two businesses of the main "Pharmacy Business" and the "Medical-Related Business," which is independent of government policies.
- ※Due to the addition of the Pharmaceutical Manufacturing Business, the name of the "BPO Business" was changed to "Medical-Related Business" from FY2020.
Pharmacy Business
With the slogan "Peace of mind closest to you," we are developing a variety of forms of "Qol Pharmacies" based on convenience for users, including one-on-one pharmacies with medical institutions.
Medical-Related Business
The Medical-Related Business consists of the BPO Business and the Pharmaceutical Manufacturing Business.
The Medical-Related Business, with APO PLUS STATION as the core company, consists of the MR (medical representative) and medical staff dispatch/referral business, and the publishing-related business.
The Medical-Related Business is a business area with high profitability and growth potential and supports the performance of the Qol Group as the second pillar.
The Pharmaceutical Manufacturing Business is the business of Fujinaga Pharm Co., Ltd., which became a subsidiary in 2019. By investing in manufacturing equipment and expanding sales to our group's dispensing pharmacies, we are promoting business development that makes the most of the group's strengths.
- ※CSO（Contact Sales Organization）：Contracted drug sales services.
- ※CRO（Contract Research Organization）：Contracted drug development services.
Sales/operating income composition ratio by business segment (fiscal year ended March 31, 2023)
